Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company operates as a clinical research organization. It specializes in clinical trials, medical imaging, medical writing, data management, bioanalytical, etc
Lambda Therapeutic Research Limited, is an unlisted public company incorporated on 27 October, 1998. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 5.00 cr and the total paid-up capital is INR 4.16 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Bindi Binish Chudgar
Shareholder
|
00080578 | 19 years |
Director | Binish Hasmukh Chudgar
Shareholder
|
00119503 | 27 years |
Director | Imran Ehtiram Ali Ahmad | 00546259 | 19 years |
Director | Surender Kumar Tuteja | 00594076 | 2 years |
Director | Rikin Dilipbhai Mody
Shareholder
|
01754768 | 16 years |
Director | Nikur Dilipkumar Mody
Shareholder
|
01827634 | 11 years |
Director | Piyush Jashawantlal Shah | 06834051 | 11 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Bank Limited
No. of Loans: 1
Total Amount : 12.0 cr
THE INDUSIND BANK LIMITED
No. of Loans: 1
Total Amount : 5.0 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 5.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
LAMBDA CLINICAL SERVICES LIMITED | Gujarat | 2016 | ₹ 3.0 Cr |
L amb d a Therapeutic Ltd. | United Kingdom | - | - |
Lambda Therapeutic Research Inc, USA | United States | - | - |
N O V U M PHARMACEUTICAL RESEARCH SERVICES INC | Canada | - | - |
L a m b d a Therapeutic Research Sp.Z.o.o | Poland | - | - |
Jina Pharmaceutical Inc., USA | United States | - | - |
Read more
The incorporation date of LAMBDA THERAPEUTIC RESEARCH LIMITED is 27 October, 1998
The authorized share capital of LAMBDA THERAPEUTIC RESEARCH LIMITED is INR ₹ 5.0 Cr.
The paid-up capital of LAMBDA THERAPEUTIC RESEARCH LIMITED is INR ₹ 4.2 Cr.
The registered address of LAMBDA THERAPEUTIC RESEARCH LIMITED is Lambda House, Plot No. 38, Survey No. 388, Near Silver Oak Club, Off S.G. Highway, Gota Ahmedabad Ahmedabad Gujarat - 382481
The CIN number of LAMBDA THERAPEUTIC RESEARCH LIMITED is U24236GJ1998PLC034883.